AIFF
Firefly Neuroscience, Inc.NASDAQTechnologyAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
3.58
P/S
25.76
EV/EBITDA
-1.36
DCF Value
$0.00
FCF Yield
-28.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.5%
Operating Margin
-753.5%
Net Margin
-1741.0%
ROE
-230.0%
ROA
-189.8%
ROIC
-112.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $412.0K | $-2.5M | $-0.20 |
| FY 2025 | $1.1M | $-19.9M | $-1.82 |
| Q3 2025 | $388.0K | $-2.6M | $-0.20 |
| Q2 2025 | $299.0K | $-1.8M | $-0.14 |
Trading Activity
Insider Trades
View AllCompany Info
Sector
Technology
Industry
—
Country
CA
Exchange
NASDAQ
Beta
1.93
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.